Author:
Bradley John S.,Jackson Mary Anne,
Abstract
Appropriate prescribing practices for fluoroquinolones are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in children becomes better defined. Earlier recommendations for systemic therapy remain; expanded uses of fluoroquinolones for the treatment of certain infections are outlined in this report. Although fluoroquinolones are reasonably safe in children, clinicians should be aware of the specific adverse reactions. Use of fluoroquinolones in children should continue to be limited to treatment of infections for which no safe and effective alternative exists.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology, and Child Health
Reference69 articles.
1. Toxicological studies on pipemidic acid. V. Effect on diarthrodial joints of experimental animals;Tatsumi;J Toxicol Sci,1978
2. Juvenile canine drug-induced arthropathy: clinicopathological studies on articular lesions caused by oxolinic and pipemidic acids;Gough;Toxicol Appl Pharmacol,1979
3. The use of systemic fluoroquinolones;American Academy of Pediatrics, Committee on Infectious Diseases;Pediatrics,2006
4. Clinical practice guideline: acute otitis externa;Rosenfeld;Otolaryngol Head Neck Surg,2006
5. US Food and Drug Administration. Drug approval package [ciprofloxacin]. Available at: www.accessdata.fda.gov/drugsatfda_docs/nda/2004/019537s49_19847s27_19857s31_20780s13TOC.cfm. Accessed June 30, 2010
Cited by
130 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献